Yale New Haven Health named Thomas “Tom” Jackiewicz chief executive officer, effective Feb. 1, 2027. Jackiewicz has been president of the University of Chicago Health System since 2020 and has led three academic health systems.
He previously was CEO of Keck Medicine of USC, the University of Southern California’s health system, from 2012 to 2020, and CEO of the University of California San Diego Health System from 2009 to 2011, after two years as chief financial officer of Health Sciences.
Jack Callahan, chair of the Yale New Haven Health Board of Trustees, said: “Tom is a seasoned and innovative leader with a proven ability to help academic health systems grow, strengthen performance and expand access to exceptional care. Throughout the search process, we were particularly impressed by his ability to understand the unique needs of an organization and its market and build a strategy around those needs, rather than rely on a single playbook. Just as important, Tom has demonstrated throughout his career that he values people, collaboration, and strong partnerships with physicians and academic leaders.”
During Jackiewicz’s six years at the University of Chicago health system, operating revenue more than doubled and operating profit increased more than sixfold. He also advanced the system’s focus on health equity and serving Chicago’s South Side. The University of Chicago Medical Center improved its Vizient ranking for access to care from 34th in 2020 to eighth in 2026. He led strategies to improve patient access and capacity and pursued uses of artificial intelligence, including automating call center tasks to improve patient experience and access. Modern Healthcare named Jackiewicz one of its 100 Most Influential People in Healthcare in 2025.
“Yale New Haven Health has an extraordinary foundation as an academic health system, with tremendous clinical expertise, talented people and an important responsibility to the communities it serves,” Jackiewicz said. “I am excited by the opportunities ahead and honored to join the organization at such an important point in its evolution. I look forward to working with colleagues across the health system, Yale School of Medicine and Yale University to build on that foundation and shape the next chapter of Yale New Haven Health.”
Pamela Sutton-Wallace has served as acting CEO of Yale New Haven Health since June.
Callahan said: “Under Pam’s leadership, Yale New Haven Health has continued to advance key strategic and operational priorities, including improvements in quality and safety, strengthened financial performance, and preparations for the opening of the Adams Neurosciences Center.”
The appointment follows a national search led by a nine-member trustee search committee.